2021 American Transplant Congress » Liver 2

7:30pm-7:40pm

Waitlist Outcomes for Patients with Hepatocellular Carcinoma Following the 2019 Exception Policy Change

K. Young¹, C. Enestvedt², W. Naugler¹, E. Maynard², A. Mitra¹, M. Wungiranirun¹, J. Jou¹, J. Ahn¹, M. Chang¹, D. Lhewa¹

7:40pm-7:50pm

Severe Hypoxemia After Liver Transplantation in the Hepatopulmonary Syndrome

J. Doi, M. Fujiki, G. DAmico, K. Sasaki, T. Diago, F. Aucejo, C. Kwon, B. Eghtesad, K. Hashimoto, C. Miller, Q. Cristiano

7:50pm-8:00pm

Long Term Survival After Liver Transplantation for Advanced, Unresectable Intrahepatic Cholangiocarcinoma

R. R. McMillan¹, S. Kodali¹, M. Javle², A. Saharia¹, C. M. Mobley¹, M. J. Hobeika¹, A. Shetty¹, D. W. Victor¹, R. McFadden¹, M. Abdelrahim¹, K. Heyne¹, A. O. Gaber¹, R. M. Ghobrial¹

8:00pm-8:10pm

Should We Curtail the Importance of Non-modifiable Risk Factors in Dcd Liver Risk Stratification?

R. Meier¹, Y. Kelly², S. Yamaguchi², H. Braun², T. Lunow-Luke², D. Adelmann², C. Niemann², D. Maluf¹, Z. Dietch², P. Stock², S. Kang², S. Feng², A. Posselt², J. Gardner², C. Freise², R. Hirose², C. Freise², N. Ascher², J. Roberts², G. Roll²

8:10pm-8:20pm

The Intersection of Cost, Quality, and Volume in Liver Transplant

D. Axelrod¹, R. Balakrishnan¹, A. Harris², S. Hohmann², J. Snyder³, B. Kasiske³, M. Schnitzler⁴, K. Lentine⁴